Overview of pediatric psychopharmacology

Sigita Plioplys, Jennifer Kurth, Mary Lou Gutierrez

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

INTRODUCTION Clinical practice of pediatric psychopharmacology is challenging for several reasons. Over the past 10 years, there has been significant increase in the use of psychotropic medications in the pediatric population. The largest increase was the use of atypical antipsychotics (138.4%), atypical antidepressants (42.8%), and selective serotonin reuptake inhibitors (18.8%) (1). Although treatment with psychotropic drugs is usually managed by a child and adolescent psychiatrist, a large proportion of children receive these medications from primary care doctors and pediatric specialists. Off-label medication use and constantly emerging new Food and Drug Administration (FDA) warnings and regulations issued by medical professional organizations require clinicians to have access and up-to-date training in clinical pharmacology.

Original languageEnglish (US)
Title of host publicationSleep and Psychiatric Disorders in Children and Adolescents
PublisherTaylor and Francis
Pages365-382
Number of pages18
ISBN (Electronic)9781420048087
ISBN (Print)1420048074, 9781420048070
DOIs
StatePublished - Jan 1 2008

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Overview of pediatric psychopharmacology'. Together they form a unique fingerprint.

Cite this